Pediatric and Adolescent/Young Adult High‐Grade Gliomas With Adult‐Type Molecular Features
Pathology International · 2026-01 · 76 (1)
DOI: 10.1111/pin.70087 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology International, online erschienen am 27.01.2026. Verfasst von Jyotsna Singh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Neuropathology Laboratory, Neurosciences Centre, All India Institute of Medical Sciences, New Delhi, India. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Indian Council of Medical Research, India, Indian Council of Medical Research.
Abstract (Originalsprache)
High‐grade gliomas (HGGs) in pediatric and adolescent/young adult (AYA) patients are biologically heterogeneous. Most exhibit pediatric‐type molecular features, but a subset shows adult‐type DNA methylation profiles with distinct diagnostic and therapeutic implications. We retrospectively analyzed 60 consecutive HGG, NOS cases in patients aged 0–39 years. Genome‐wide DNA methylation profiling was performed using two independent brain tumor classifiers, with parallel copy‐number analysis, and final diagnoses were reached by integrating epigenetic signatures with histopathology; targeted next‐generation sequencing was undertaken in selected tumors. Adult‐type molecular profiles were identified in 14 of 60 cases (23.3%), comprising 11 glioblastomas, IDH‐wildtype (GBM RTK I, RTK II, and mesenchymal) and 3 adult‐type diffuse high‐grade gliomas, IDH‐wildtype, subtype B, with 35.7% (5/14) occurring in patients ≤ 18 years. Recurrent alterations included NF1 (87.5%), PTEN (62.5%), and TERT promoter mutations (25%), with a single BRAF V600E‐mutant tumor, while the classical +7/ − 10 signature was infrequent and MGMT promoter methylation was largely absent in GBM, IDH‐wildtype. This study demonstrates that a substantial subset of pediatric and AYA HGGs harbor molecularly adult‐type signatures, revealing the limitations of conventional histopathology and immunohistochemistry, challenging age‐based diagnostic paradigms, and highlights the value of methylation profiling for diagnostic refinement, detection of targetable alterations in younger patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neuropathology Laboratory, Neurosciences Centre, All India Institute of Medical Sciences, New Delhi, India.
- Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India.
- Department of Neuroimaging and Interventional Neuroradiology, All India Institute of Medical Science, New Delhi, India.
- Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
ORCID-Profile: Ajay Garg, Mehar Chand Sharma, Chitra Sarkar, Vaishali Suri
Förderung
- Indian Council of Medical Research, India
- Indian Council of Medical Research
Zitieren
APA
Singh, J., Bhardwaj, S., Singh, S., Mansoori, S., Vasant, S., Srivastava, K., Kedia, S., Garg, A., Suri, A., Sharma, M. C., Sarkar, C., & Suri, V. (2026). Pediatric and Adolescent/Young Adult High‐Grade Gliomas With Adult‐Type Molecular Features. Pathology International, 76(1). https://doi.org/10.1111/pin.70087
Vancouver
Singh J, Bhardwaj S, Singh S, Mansoori S, Vasant S, Srivastava K, et al. Pediatric and Adolescent/Young Adult High‐Grade Gliomas With Adult‐Type Molecular Features. Pathology International. 2026;76(1). doi:10.1111/pin.70087
BibTeX
@article{Singh2026,
author = {Singh, Jyotsna and Bhardwaj, Supriya and Singh, Swati and Mansoori, Shabnam and Vasant, Srinidhi and Srivastava, Kirti and Kedia, Shweta and Garg, Ajay and Suri, Ashish and Sharma, Mehar Chand and Sarkar, Chitra and Suri, Vaishali},
title = {Pediatric and Adolescent/Young Adult High‐Grade Gliomas With Adult‐Type Molecular Features},
journal = {Pathology International},
year = {2026},
volume = {76},
number = {1},
doi = {10.1111/pin.70087}
}
EUVIMED